Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccine
- 30 December 2011
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 53 (3), 239-243
- https://doi.org/10.1016/j.jcv.2011.12.009
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- International collaborative proficiency study of Human Papillomavirus type 16 serologyVaccine, 2012
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsNew England Journal of Medicine, 2007
- Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccineVaccine, 2007
- Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessingInternational Journal of STD & AIDS, 2006
- Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Vaccine, 2006
- Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacyInternational Journal of STD & AIDS, 2006
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18Clinical and Vaccine Immunology, 2005
- Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: A 2-Year Randomized Controlled Clinical TrialMayo Clinic Proceedings, 2005
- Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex AssayClinical and Vaccine Immunology, 2003